포트리아와 오미코, 바이오마커 기반 항암 신약 개발 발전 위한 협력 추진

Fortrea, a leading clinical research organization, has partnered with Omico, Australia's precision oncology testing and clinical trial matching organization, to accelerate biomarker-based cancer research in Australia. The collaboration combines Fortrea's oncology clinical trial expertise with Omico's PrOSPeCT platform to improve patient-trial matching, enhance site selection efficiency, and expand access to precision oncology research globally.